Low back pain affects an estimated one in four American adults and is the leading contributor to disability globally. In most ...

A new review of the evidence finds that only a handful of common remedies provide a modest benefit for acute or chronic back ...

Contrary to popular belief, young adults can experience significant acute and even chronic pain—which can motivate them to ...

Only one in ten treatments for back pain actually work, and those that do are barely better than a placebo, a study from the ...

Only around one in 10 common non-surgical and non-invasive treatments for lower back pain are effective, suggests a pooled ...

Contrary to popular belief, young adults can experience significant acute and even chronic pain - which can motivate them to ...

MAXONA Pharmaceuticals today announced the preliminary results of the Phase 1 clinical program for MAX-001, which is in development as a New Molecular Entity (NME), non-opioid, non-NSAID oral therapy ...

But a new study has found that only one in 10 treatments for lower back pain are effective, with those that improve symptoms ...

Only around 1 in 10 common non-surgical and non-invasive treatments for lower back pain is effective, suggests a pooled data analysis of the available ...

Chronic inflammation is a serious health issue that requires careful management. Here is how following healthy lifestyle ...

Dogwood Therapeutics, Inc. ("Dogwood" or the "Company"), a development-stage biopharmaceutical company focused on advancing first-in-class, non-opioid, treatments for chronic and acute pain, announces ...

The VER-01 therapy – a cannabis extract that includes the full range of cannabinoid compounds including low levels of THC – was effective as a treatment for chronic lower back pain in a pair of ...